ASX Share rice
Wed 12 Aug 2020 - 11:08:am (Sydney)

PME Share Price

PRO MEDICUS LIMITEDPMEHealth Care Equipment & Services

PME Company Information

Name:

Pro Medicus Limited

Sector:

Technology

Industry:

Healthcare Information Services

GIC Industry:

Health Care Technology

GIC Sub Industry:

Health Care Technology

Address:

450 Swan Street Richmond VIC Australia 3121

Phone:

61 3 9429 8800

Co-Founder, Deputy Chairman, CEO & MD:

Dr. Sam Aaron Hupert

Co-Founder, Technology Director & Exec. Director:

Mr. Anthony Barry Hall B.Sc.(Hons), M.Sc.

Global Chief Technology Officer:

Dr. Malte Westerhoff

GM of North America & Global Head of Marketing:

Mr. Brad Levin

Gen. Mang. of Australia:

Mr. Danny Tauber

Company Overview:

Pro Medicus Limited provides radiology information systems (RIS), picture archiving and communication systems (PACS), and advanced visualization solutions in Australia, Europe, and North America. It offers medical software for practice management; integration products; Promedicus.net secure email; healthcare software that provides radiologist and clinicians with advanced visualization capability for viewing 2-D, 3-D, and 4-D medical images; and PACS/Digital imaging software. The company offers its products under the Visage RIS, Visage RIS/PACS, and Visage 7 names. It also provides Visage Ease Pro, a mobile applications, which allow users access to medical imaging results that are stored on a Visage 7 server; training, installation, and professional services; and after sale support and service products. The company offers its products and services to hospitals, diagnostic imaging groups, and other health related entities. Pro Medicus Limited was founded in 1983 and is headquartered in Richmond, Australia.

PME Share Price Information

Shares Issued:

103.95M

Market Capitalisation:

$2.40B

Dividend per Share:

$0.1

Ex Dividend Date:

2020-03-05

Dividend Yield:

0.43%

Revenue (TTM):

$54.08M

Revenue Per Share (TTM):

$0.52

Earnings per Share:

$0.211

Profit Margin:

0.4086

Operating Margin (TTM):

$0.51

Return On Assets (TTM):

$0.22

Return On Equity (TTM):

$0.47

Quarterly Revenue Growth (YOY):

0.157

Gross Profit(TTM):

$48.70M

Diluted Earnings Per Share (TTM):

$0.211

QuarterlyEarnings Growth(YOY):

0.326

PME CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-7,305,000

Change To Liabilities:

$7.29M

Total Cashflow From Investing Activities:

$-7,305,000

Net Income:

$19.13M

Total Cash From Operating Activities:

$24.66M

Depreciation:

$191K

Other Cashflow From Investing Activities:

$244K

Dividends Paid:

$-9,843,000

Change To Inventory:

$23K

Change To Account Receivables:

$-9,089,000

Capital Expenditures:

$7.55M

PME Income Statement

Income Date:

2019-06-30

Income Before Tax:

$26.12M

Net Income:

$19.13M

Gross Profit:

$48.67M

Operating Income:

$25.44M

Other Operating Expenses:

$776K

Income Tax Expense:

$7M

Total Revenue:

$50.08M

Total Operating Expenses:

$23.23M

Cost Of Revenue:

$1.41M

PME Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$18.17M

Total Liabilities:

$34.99M

Total Stockholder Equity:

$49.29M

Other Current Liabilities:

$11.27M

Total Assets:

$84.28M

Common Stock:

$1.96M

Other Current Assets:

$1.99M

Retained Earnings:

$37.46M

Other Liabilities:

$21.07M

Other Assets:

$13.15M

Cash:

$32.32M

Total Current Liabilities:

$13.92M

Property - Plant & Equipment:

$503K

Net Tangible Assets:

$31.12M

Total Current Assets:

$52.46M

Net Receivables:

$17.86M

Short-Term Investments:

$31.82M

Inventory:

$31K

Accounts Payable:

$705K

Non Currrent Assets (Other):

$516K

Short-Term Investments:

$31.82

Non Current Liabilities Total:

$21.07M

PME Share Price History

PME News

12 Jul, 2020
It is hard to get excited after looking at Pro Medicus' (ASX:PME) recent performance, when its stock has declined 8.9...
26 Jun, 2020
13:00
Yahoo! Finance
Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced the latest version of the Visage® 7 Enterprise Imaging Platform, Visage 7.1.15, has been released for global availability. Visage is scheduling online demonstrations of Visage 7 coinciding with the virtual Society for Imaging Informatics in Medicine 2020 (SIIM20) annual meeting, June 24-26.
24 Apr, 2020
We think all investors should try to buy and hold high quality multi-year winners. And we've seen some truly amazing...
19 Mar, 2020
Pro Medicus Limited (ASX:PME), which is in the healthcare services business, and is based in Australia, saw...
23 Feb, 2020
In 2010 Sam Hupert was appointed CEO of Pro Medicus Limited (ASX:PME). This report will, first, examine the CEO...
17 Jan, 2020
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
13 Dec, 2019
If you own shares in Pro Medicus Limited (ASX:PME) then it's worth thinking about how it contributes to the volatility...
01 Dec, 2019
Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced Visage will demonstrate semantic annotations for the Visage® 7 Enterprise Imaging Platform as a works-in-progress, at the Radiological Society of North America (RSNA) 2019 annual meeting (Visage Booth 7524, McCormick Place-North Hall), December 1-5, in Chicago, Illinois.
15 Nov, 2019
Unifies AI, delivers growth and proven results SAN DIEGO , Nov. 15, 2019 /PRNewswire/ -- Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced ...
12 Nov, 2019
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

PME Dividend Payments

EX-Date Dividend Amount
2010-09-10$0.0200
2012-02-29$0.0050
2012-09-10$0.0100
2013-03-03$0.0100
2013-09-09$0.0100
2014-03-02$0.0100
2014-09-10$0.0100
2015-03-03$0.0100
2015-09-09$0.0100
2016-03-09$0.0150
2016-09-08$0.0150
2017-03-08$0.0150
2017-09-07$0.0250
2018-03-07$0.0250
2018-09-06$0.0350
2019-03-06$0.0350
2019-09-12$0.0450
2020-03-04$0.0600

PME Dividends (last 10 Years)